The venture capital fund Sunstone Capital is ready with new ‘risk-willing’ capital for the money-starved biotech companies. The companies should shape themselves according to the demands of investors, and consequently company-structures will look very different in the future, assesses Peter Benson – leading partner in the fund.
“I think that we are going to see differently shaped companies in the future. These will be companies that are more focused, have less administrative top structure, have more active boards and are more industry-oriented. That‘s the tendency that we see,” he says.